Anti-tumour promoting activity of diphenylmethyl selenocyanate against two-stage mouse skin carcinogenesis

Asian Pacific Journal of Cancer Prevention

Volumn 6, Issue 2, 2005, Pages 181-188

  Das, Rajat Kumar ^a   Bhattacharya, Sudin ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Antitumour promoter; Croton oil; Diphenylmethyl selenocyanate; DMBA; Lipid peroxidation; Phase II enzymes

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; CROTON OIL; CYANIC ACID DERIVATIVE; SELENIUM DERIVATIVE; SELENOCYANIC ACID;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; ENZYMOLOGY; FEMALE; LIPID PEROXIDATION; MOUSE; PAPILLOMA; SKIN TUMOR;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANALYSIS OF VARIANCE; ANIMALS; ANTICARCINOGENIC AGENTS; CROTON OIL; CYANATES; FEMALE; LIPID PEROXIDATION; MICE; PAPILLOMA; SELENIUM COMPOUNDS; SKIN NEOPLASMS;

EID: 24944564769     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Allen SM, Florell SR, Hanks AN, et al (2003). Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression. Cancer Res, 63, 567-72.
2. Angus WG, Larsen MC, Jefeoate CR (1999). Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status. Carcinogenesis, 20, 947-55.
3. Buters JTM, Sakai S, Richter T, et al (1999). Cytochrome p450 CYP1B1 determines susceptibility to 7, 12- dimethylbenz (a) anthracene - induced lymphomas. Proc Natl Acad Sci USA, 96, 1977-82.
4. Cheng SC, Prakash AS, Pigott MA, et al (1988a). Characterization of 7, 12- dimethylbenz (a) anthracene-adenine nucleoside adducts. Chem Res Toxicol, 1, 216-21.
5. Cheng SC, Prakash AS, Pigott MA, et al (1988b). A metabolite of the carcinogen 7, 12 - dimethylbenz (a) anthracene that reacts predominantly with adenine residues in DNA. Carcinogenesis, 9, 1721-3.
6. Curphey TJ, Kuhlmann ET, Roebuck BD, Longnecker DS (1988). Inhibition of pancreatic and liver carcinogenesis in rats by retinoid and selenium-supplemented diets. Pancreas, 3, 36-40.
7. Das RK, Bhattacharya S (2004). Inhibition of DMBA-croton oil two-stage mouse skin carcinogenesis by diphenylmethyl selenocyanate through modulation of cutaneous oxidative stress and inhibition of nitric oxide production. Asian Pacific J Cancer Prev, 5, 151-8.
8. Das RK, Ghosh S, Sengupta A, Das S, Bhattacharya S (2004). Inhibition of DMBA/croton oil-induced two-stage mouse skin carcinogenesis by diphenylmethyl selenocyanate. European J Cancer Prev, 13, 411-7.
9. El-Bayoumy K, Rao CV, Reddy BS (2001). Multiorgan sensitivity to anticarcinogenesis by the organoselenium 1,4-phenylenebis(methylene)selenocyanate. Nutrition and Cancer, 40, 18-27.
10. Fischer SM, Lee ML, Maldve RE, et al (1993). Association of protein kinase C activation with induction of ornithine decarboxylase in murine but not human keratinocyte cultures. Mol Carcinog, 7, 228-37.
11. Gerald F, Combs Jr, William PG (1998). Chemopreventive agents: Selenium. Pharmacol Ther, 3, 179-92.
12. Ghosh S, Das RK, Sengupta A, Bhattacharya S (2004). Induction of apoptosis and inhibition of cell proliferation by diphenylmethyl selenocyanate during azoxymethane induced rat colon carcinogenesis. International J Cancer Prev, 5, (in press).
13. 2+- and phospholipidindependent activation of protein kinase C by selective oxidative modification of regulatory domain. Proc Natl Acad Sci USA, 86, 6758-62.
14. Gopalakrishna R, Anderson WB (1991). Reversible oxidative activation and inactivation of protein kinase C by the mitogen/tumor promoter periodate. Arch Biochem Biophys, 285, 382-7.
15. Gopalakrishna R, Jaken S (2000). Protein kinase C and oxidative stress. Free Radic Biol Med, 28, 1349-61.
16. Habig WH, Pabst MJ, Jacoby WB (1974). Glutathione-STransferases, the first enzymatic step in marcapturic acid formation. J Biol Chem, 249,7130-9.
17. Ip C (1985). Selenium inhibition of chemical carcinogenesis. Fed Proc, 44, 2573-8.
18. Ip C, Daniel FB (1985). Effects of selenium on 7,12-dimethylbenz (α) anthracene-induced mammary carcinogenesis and DNA adduct formation. Cancer Res, 45, 61-5.
19. Ip C, Ip M (1981). Chemoprevention of mammary tumorigenesis by a combined regimen of selenium and vitamin A. Carcinogenesis, 9, 915-8.
20. Ip C, Ip M, Kim U (1981). Dietary selenium intake and growth of the MT-W9B transplanted rat mammary tumor. Cancer Lett, 14, 101-7.
21. Jacobs M (1983). Selenium inhibition of 1,2-dimethylhydrazineinduced colon carcinogenesis. Cancer Res, 43, 1646-9.
22. Kausar H, Bhasin G, Zargar MA, Athar M (2003). Palm oil alleviates 12-Otetradecanoyl- phorbol-13-acetate-induced tumor promotion response in murine skin. Cancer Lett, 192, 151-60.
23. Kawajiri K (1999). CYP1A1, IARC Scientific Publications, Chapter 15, IARC, Lyon, pp. 159-172.
24. Larsson R, Cerutti P (1989). Translocation and enhancement of phosphotransferase activity of protein kinase C following exposure of mouse epidermal cells to oxidants. Cancer Res, 49, 5627-33.
25. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951). Protein measurement with Folinphenol reagent. J Biol Chem, 193, 265-76.
26. Lu J, Kaeck M, Jiang C, Wilson AC, Thompson HJ (1994). Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem Pharmacol, 47, 1531-5.
27. Luck HA (1963). Spectrophotometric method for estimation of catalase. In 'Methods of Enzymatic Analysis' Ed Bergmeyer HV. Academic Press, New York, pp. 886-888.
28. Marklund S, Marklund G (1974). Involvement of the superoxide anion radical in the oxidation of pyrogallol and a convenient assay for superoxide dismutase. Europ J Biochem, 47, 469-74.
29. Matsumoto K, Inagaki T, Hirunuma R, Enomoto S (2001). Contents and uptake rates of Mn, Fe, Co, Zn, and Se in Se-deficient rat liver cell fractions. Analyt Sci, 17, 587-91.
30. Mc Cord JM, Fridovich I (1969). Superoxide dismutase: An enzymatic function for erythrocuprein (hemoprotein). J Biol Chem, 244, 6049-55.
31. McCormick DL, Rao KVN, Dooley L, et al (1998). Influence of N-methyl-N-nitrosourea, testosterone and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats. Cancer Res, 58, 3282-8.
32. McCormick DL, Rao KVN, Steele VE, et al (1999). Chemoprevention of rat prostate carcinogenesis by 9-cisretinoic acid. Cancer Res, 59, 521-4.
33. Medina D, Shephard F (1980). Selenium-mediated inhibition of mouse mammary tumorigenesis. Cancer Lett, 8, 241-5.
34. Mulder TPJ, Manni JJ, Roelofs HMJ, Peters WHM, Wiersma A (1995). Glutathione-S-transferases and glutathione in human head and neck cancer. Carcinogenesis, 16, 619-24.
35. Murakami A, Ohigashi H, Koshimizu K (1996). Anti-tumor promotion with food phytochemicals: a strategy for cancer prevention. Biosci Biotechnol Biochem, 60, 1-8.
36. Murakami A, Ohigashi H, Koshimizu K (1999). Chemoprevention: insights into biological mechanisms and promising food factors. Food Rev Int, 15, 335-95.
37. O'Brien TG, Megosh LC, Gilliard G, Soler AP (1997). Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cance Res, 57, 2630-7.
38. Oberley TD, Oberley LW (1993). Oxygen radicals and cancer. In 'Free Radicals in Aging' Ed Yu BP. CRC Press, Boca Raton, FL, pp. 247-267.
39. Okhawa H, Ohishi N, Yagi K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Annal Biochem, 95, 351-8.
40. Pedersen CTh (1963). Preparation of some 4-substituted selenosemicarbazides. Acta Chemica Scandinavica, 17, 1459-61.
41. Schrauzer GN, White DA, Schneider CJ (1977). Cancer mortality correlations studies. III. Statistical association with dietary selenium intakes. Bioinorg Chem, 7, 35-56.
42. Senmez H, _zturk Z, Ekmekci H, Baloglu H, K_koglu E (2003). TBARS, Carnitine, and reduced glutathione levels in human bladder carcinoma. Biochem (Moscow), 68, 346-8.
43. Singh N, Poirier G, Cerruti P (1985). Tumor promoter PMA induces poly ADP ribosylation in fibroblasts. EMBO J, 4, 1491-4.
44. Slaga TJ, Budunova IV, Gimenez-Conti IB, Aldaz CM (1996). The mouse skin carcinogenesis model. J Invest Dermato Symposium Proceedings, 1, 151-6.
45. Tempero MA, Deschner EE, Zedeck MS (1986). The effect of selenium on cell proliferation in liver and colon. Biol Trace Elem Res, 127, 9-14.
46. Thompson HJ, Becci PJ (1980). Selenium inhibition on N-methyl-N-nitrosourea-induced mammary tumorigenesis in the rat. J Natl Cancer Inst, 65, 1299-301.
47. Thompson HJ, Meeker LD, Becci PJ (1981). Effect of combined selenium and retinyl acetate treatment on mammary carcinogenesis. Cancer Res, 41, 1413-6.
48. Thompson HJ, Wilson A, Lu J, et al (1994). Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis, 15, 183-6.
49. Warren BS, Naylor MF, Winberg LD (1993). Induction and inhibition of tumor progression. Proc Soc Exp Biol Med, 202, 9-15.
50. Watrach AM, Milner JA, Poirier KA (1984). Inhibition of human breast cancer cells by selenium. Cancer Lett, 25, 41-2.
51. 2 toxicity. Carcinogenesis, 16, 1579-84.